LPO and COVID-19: Finally, the integration of the two omics approaches (exome- and transcriptome-based) pinpointed a single gene, LPO, which was significantly enriched in damaging rare variants in patients with COVID-19, and was also significantly upregulated in ICU-admitted individuals (Fig. 3A and B).